Your Story Matters – Marilyn’s Message August 2023
At CDF, we deeply value hearing stories from our patient community. Your stories are a pivotal part of our efforts to build awareness and fight for research funding.
Continue ReadingAt CDF, we deeply value hearing stories from our patient community. Your stories are a pivotal part of our efforts to build awareness and fight for research funding.
Continue ReadingThe Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled “Celiac Disease: On the Horizon”. Recording available now.
Continue ReadingAn international study exploring the molecular characteristics of celiac disease identified several genes highly associated with the disease. This new study uncovered that these genes play a pivotal role in regulating celiac disease’s immune response.
Continue ReadingEach month in our advocacy newsletter, the Celiac Disease Foundation highlights one of our many dedicated advocates as part of our Patient Profile Series.
Continue ReadingThe ACeD-it Study is looking for adult volunteers with celiac disease to join a phase 1b/2 clinical trial. Your participation could make a difference.
Continue ReadingThe Celiac Disease Foundation, is proud to announce a recent grant of $200,000 from the Foster Family Foundation, which CDF will use to further its mission.
Continue ReadingThe Celiac Disease Foundation today announces the departure of Chief Development Officer Deborah Ceizler, who has served in key roles for more than 18 years.
Continue ReadingResearch is pivotal to the mission of the Celiac Disease Foundation, and so I’m excited to provide you with an update on the groundbreaking findings of a recent study conducted for the European Union’s Joint Research Centre (JRC).
Continue ReadingWant to get involved in celiac disease research? It’s time to take action. The TEV-CeD Study is a phase 1b clinical trial testing the investigational medication TEV-53408 for the treatment of celiac disease.
Continue ReadingNew research indicates that a specific set of natural memory T cells, when triggered by gluten, rapidly become destructive and cause intestinal damage in celiac disease patients.
Continue Reading